Income-based disparities in the care and outcomes experienced by patients with acute myocardial infarction (MI) are seen around the world, despite vastly different healthcare and social safety net ...

Please provide your email address to receive an email when new articles are posted on . Risk factors for patients with acute MI have changed modestly as treatment has improved, with mortality rates ...

Please provide your email address to receive an email when new articles are posted on . Heart attacks, both STEMI and non-STEMI, declined less for men vs. women from 2011 to 2018. Women received ...

"So that led to much higher mortality rates than seen in previous studies," Roe added. Unadjusted in-hospital mortality rates were 12.5% for non-STEMI patients and 14.3% for STEMI patients (p<0.001).

SAN FRANCISCO -- For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, there was no clinical benefit to a strategy of finding and treating all nonculprit ...

Late ventricular fibrillation after acute myocardial infarction is associated with a markedly increased risk of 1-year ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ATLANTA -- ...

Noninferiority was not demonstrated between immediate and staged complete revascularisation in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease undergoing ...

The benefits of complete revascularization over culprit-only coronary artery revascularisation were confirmed in older patients with ST-segment elevation myocardial infarction (STEMI) and multivessel ...

For STEMI patients undergoing primary PCI, there are no significant differences in the risks of death, MI, or stroke between those treated with prasugrel and those who received ticagrelor, nor are ...